Form 4: PROCEPT BioRobotics Director Thomas Prescott Reports New Equity Awards

PROCEPT BioRobotics Corp. Director Thomas M. Prescott reported the acquisition of 1,538 restricted stock units and 2,771 stock options on June 10, 2025, as part of his compensation.

Summary

• Thomas M. Prescott, a Director of PROCEPT BioRobotics Corp. (PRCT), reported changes in his beneficial ownership of company securities.
• On June 10, 2025, Mr. Prescott acquired 1,538 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0.
• These RSUs represent a contingent right to receive one share of Common Stock each and are set to vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Additionally, on June 10, 2025, Mr. Prescott was granted 2,771 Stock Options (Right to Buy) with an exercise price of $64.23 per share.
• These stock options also vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service, and have an expiration date of June 9, 2035.
• Following these transactions, Mr. Prescott beneficially owns 3,896 shares of Common Stock directly and 2,771 derivative securities (Stock Options) directly.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 7

Explanation: The grant of equity awards to a director is generally viewed positively as it aligns the director's financial interests with the long-term performance of the company, benefiting shareholders. It is a routine compensation event and does not indicate any immediate negative operational or financial issues.

Positives

• The grant of restricted stock units and stock options to a director aligns management's interests with those of shareholders, as the value of these awards is tied to the company's stock performance.
• The use of a Rule 10b5-1 plan indicates a pre-arranged and compliant approach to insider transactions, enhancing transparency and reducing concerns about opportunistic trading.

Future Outlook

The vesting conditions for both the RSUs and stock options require continued service through the vesting date, which is the earlier of the one-year anniversary of the grant date or the date of the next annual meeting. This incentivizes the director's ongoing commitment to the company.

Industry Context

The grant of equity awards such as restricted stock units and stock options is a standard practice in executive and director compensation across various industries, particularly in the medical technology and robotics sectors, to attract, retain, and motivate key personnel and align their interests with long-term shareholder value.

Comparison to Industry Standards

• The structure of equity compensation, including RSUs and stock options with service-based vesting, is consistent with common practices observed in publicly traded companies within the medical device and robotics industries, such as Intuitive Surgical (ISRG) or Stryker Corporation (SYK), which frequently utilize similar mechanisms for director and executive incentives.
• The exercise price of $64.23 for the stock options is likely set at the market price on the grant date, which is a standard approach for incentive stock options.

Corporate Governance

Related Party Transactions

• The grant of equity awards (RSUs and stock options) to Thomas M. Prescott, a director of PROCEPT BioRobotics Corp., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity awards align the director's incentives with shareholder value creation, potentially leading to more focused decision-making aimed at long-term stock appreciation.
• Employees: While not directly impacted, the compensation structure for directors can reflect the company's overall approach to incentivizing key personnel.

Next Steps

• The director's continued service through the vesting period will be required for the full realization of the RSU and stock option awards.

Key Dates

Recommendation

Keywords

PROCEPT BioRobotics, PRCT, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Equity Compensation, Director Compensation, Thomas Prescott, Beneficial Ownership